| 英文名称 |
中文名称 |
CAS号 |
操作 |
| WAY-111543 |
WAY-111543 |
868269-74-3 |
详细
|
| TAK-901 |
5-[3-(乙基磺酰基)苯基]-3,8-二甲基-N-(1-甲基-4-哌啶基)-9H-吡啶并[2,3-B]吲哚-7-甲酰胺 |
934541-31-8 |
详细
|
| 2-(2,2,2-trifluoroacetyl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonyl chloride |
2-(2,2,2-三氟乙酰基)-1,2,3,4-四氢异喹啉-6-磺酰氯 |
169949-39-7 |
详细
|
| LDN-193189 (DM3189) 2HCl |
LDN-193189 2HCL |
1435934-00-1 |
详细
|
| Bevenopran |
676500-67-7 |
676500-67-7 |
详细
|
| 4-(2-(3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethyl)morpholine |
|
1426671-36-4 |
详细
|
| FL-411 |
2-(4-羟基-3,5-二甲基苯基)-7-甲基-5,6,7,8-四氢吡啶并[4',3':4,5]噻吩并[2,3-D]嘧啶-4(1H)-酮 |
2118944-88-8 |
详细
|
| KHS101 hydrochloride |
盐酸KHS101 |
1784282-12-7 |
详细
|
| Sivelestat (ONO5046, LY544349, EI546) |
西维来司他 |
127373-66-4 |
详细
|
| NEO2734 (EP31670) |
化合物NEO2734 |
2081072-29-7 |
详细
|
| Teijin Compound 1 HCl |
|
313730-14-1 |
详细
|
| AZ960 |
5-氟-2-[[(1S)-1-(4-氟苯基)乙基]氨基]-6-[(5-甲基-1H-吡唑-3-基)氨基]-3-吡啶腈 |
905586-69-8 |
详细
|
| SB 657510 |
2-溴-N-[4-氯-3-[[(3R)-1-甲基-3-吡咯烷基]氧基]苯基]-4,5-二甲氧基-苯磺酰胺 |
474960-44-6 |
详细
|
| TR-14035 |
(ALPHAS)-ALPHA-[(2,6-二氯苯甲酰)氨基]-2',6'-二甲氧基联苯-4-丙酸 |
232271-19-1 |
详细
|
| SYP-5 |
1384268-04-5 |
1384268-04-5 |
详细
|
| Teijin compound 1 |
化合物 T19230 |
1313730-14-1 |
详细
|
| A-381393 |
A-381393 |
726174-00-1 |
详细
|
| GPR40 |
GPR40/FFAR1 modulator 1 |
874755-26-7 |
详细
|
| JH-X-119-01 |
2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)- |
2227368-54-7 |
详细
|
| Dacinostat |
达诺司他 |
404951-53-7 |
详细
|
| GSK329 |
化合物 T24109 |
1268490-12-5 |
详细
|
| 2,6-DIMETHYL-4'-(TRIFLUOROMETHYL)-[1,1'-BIPHENYL]-4-OL |
2,6-二甲基-4-(三氟甲基)-[1,1-联苯]-4-醇 |
872258-58-7 |
详细
|
| PIK-93 |
N-[5-[4-氯-3-[[(2-羟基乙基)氨基]磺酰基]苯基]-4-甲基-2-噻唑基]乙酰胺 |
593960-11-3 |
详细
|
| GSK854 |
3-((6-((5-chloropyridin-2-yl)amino)pyrimidin-4-yl)amino)-4-(ethylsulfonyl)-N-methylbenzenesulfonamide |
1316059-00-3 |
详细
|
| Grp94inhibitor-1 |
GRP94 |
2234897-35-7 |
详细
|
| Perospirone |
哌罗匹隆 |
150915-41-6 |
详细
|
| PDS-0330 |
|
2904682-19-3 |
详细
|
| Toceranib |
Toceranib |
356068-94-5 |
详细
|
| WQ1 1204401-49-9 |
化合物Σ1 RECEPTOR ANTAGONIST-1 |
1204401-49-9 |
详细
|
| NMS-E973 |
NMS-E973 |
1253584-84-7 |
详细
|
| DUN61488 |
ONC212 |
1807861-48-8 |
详细
|
| UNC669 |
5-溴烟酸 |
20826-04-4 |
详细
|
| NSC 625987 |
NSC 625987 |
141992-47-4 |
详细
|
| CCR6 inhibitor 1 |
2-Pyridinecarboxamide, 4-[4-[[trans-4-[[5-(trifluoromethyl)-2-pyridinyl]amino]cyclohexyl]sulfonyl]phenyl]- |
2437547-04-9 |
详细
|
| RU-TRAAK-2 |
化合物RU-TRAAK-2 |
1210538-56-9 |
详细
|
| VU-0155069 |
CAY10593 |
1130067-06-9 |
详细
|
| BMS-833923 |
BMS-833923 |
1059734-66-5 |
详细
|
| 1H-Indazole-3,5-dicarboxylic acid 5-methyl ester |
1H-Indazole-3,5-dicarboxylic acid 5-methyl ester |
797804-53-6 |
详细
|
| YUM08164 |
1H-Pyrazole-3-carboxamide, N-(cyanomethyl)-4,5-dihydro-1,5-diphenyl- |
1333608-16-4 |
详细
|
| Dovramilast |
化合物 DOVRAMILAST |
340019-69-4 |
详细
|
| 31816-70-3 |
4-[(1,5-二甲基-3-氧代-2-苯基-2,3-二氢-1H-吡唑-4-基)氨磺酰基]苯甲酸 |
31816-70-3 |
详细
|
| NVP-BVU 972 |
6-[[6-(1-甲基-1H-吡唑-4-基)咪唑并[1,2-B]哒嗪-3-基]甲基]喹啉 |
1185763-69-2 |
详细
|
| SR-2211 |
2-Fluoro-4'-[[4-(4-pyridinylMethyl)-1-piperazinyl]Methyl]-伪,伪-bis(trifluoroMethyl)-[1,1'-biphenyl]-4-Methanol |
1359164-11-6 |
详细
|
| ZINC00881524 |
557782-81-7 |
557782-81-7 |
详细
|
| MELK-8a hydrochloride |
MELK8A HYDROCHLORIDE |
2096992-20-8 |
详细
|
| 4-(4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-5-yl)benzyl)thiomorpholine 1,1-dioxide |
1257705-09-1 |
1257705-09-1 |
详细
|
| YKL 06-061 |
YKL 06-061 |
2172617-15-9 |
详细
|
| PLX51107 |
化合物PLX51107 |
1627929-55-8 |
详细
|
| 2-[4-(4-Chlorophenoxy)phenoxy]propionic acid |
2-(4-(4-氯苯氧基)苯氧基)丙酸 |
26129-32-8 |
详细
|
| BX 513 hydrochloride |
BX 513盐酸盐 |
1216540-18-9 |
详细
|
| NTNCB hydrochloride |
2-硝基-N-[[反式-4-[[(1,2,3,4-四氢-2-萘基)甲基]氨基]甲基]环己基]甲基]苯磺酰胺盐酸盐 |
191931-56-3 |
详细
|
| H3B-120 |
H3B-120 |
2194903-42-7 |
详细
|
| ZX-29 |
ZX-29 |
2254805-62-2 |
详细
|
| ATC 0175 hydrochloride |
ATC 0175 |
510733-97-8 |
详细
|
| JC124 |
Benzamide, 5-chloro-2-methoxy-N-[2-[4-[(methylamino)sulfonyl]phenyl]ethyl]- |
1638611-48-9 |
详细
|
| Halopemide |
卤培米特 |
59831-65-1 |
详细
|
| 3,4-dimethoxy-N-[4-(3-nitrophenyl)-1,3-thiazol-2-yl]benzenesulfonamide |
RO 61-8048 |
199666-03-0 |
详细
|
| Tasquinimod |
他喹莫德 |
254964-60-8 |
详细
|
| OgleMilast |
N-(3,5-二氯吡啶-4-基)-4-二氟甲氧基-8-[(甲磺酰基)氨基]二苯并[B,D]呋喃-1-甲酰胺 |
778576-62-8 |
详细
|
| PHT-427 |
4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺 |
1191951-57-1 |
详细
|
| CC-90010 |
CC-90010 |
1706738-98-8 |
详细
|
| M4205 |
化合物M4205 |
2590556-80-0 |
详细
|
| SR15006 |
SR 15006 |
2505001-54-5 |
详细
|
| NVP-BHG712 |
4-甲基-3-[[1-甲基-6-(3-吡啶基)-1H-吡唑并[3,4-D]嘧啶-4-基]氨基]-N-[3-(三氟甲基)苯基]苯甲酰胺 |
940310-85-0 |
详细
|
| Ulixacaltamide (Z944) |
N-((1-(2-(叔丁基氨基)-2-氧代乙基)哌啶-4-基)甲基)-3-氯-5-氟苯甲酰胺 |
1199236-64-0 |
详细
|
| Ezatiostat |
EZATIOSTAT游离的 |
168682-53-9 |
详细
|
| UNC-1215 |
UNC1215 |
1415800-43-9 |
详细
|
| Sulfatinib |
5-羟基-2-甲基吲哚 |
1308672-74-3 |
详细
|
| DY 268 |
DY 268 |
1609564-75-1 |
详细
|
| LP-935509 |
化合物LP-935509 |
1454555-29-3 |
详细
|
| SB 218795 |
化合物 T23316 |
174635-53-1 |
详细
|
| 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride |
1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐 |
25952-53-8 |
详细
|
| TL02-59 |
3-(6,7-dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide |
1315330-17-6 |
详细
|
| Benzamide, 4-butoxy-N-[[4-(dimethylamino)tetrahydro-2H-pyran-4-yl]methyl]-3,5-dimethoxy-, hydrochloride (1:1) |
Opiranserin盐酸盐 |
1440796-75-7 |
详细
|
| Timapiprant sodium |
TIMAPIPRANT SODIUM |
950688-14-9 |
详细
|
| FGTI-2734 |
FGTI-2734 |
1247018-19-4 |
详细
|
| Lofepramine |
洛非帕明 |
23047-25-8 |
详细
|
| Laquinimod |
拉喹莫德 |
248281-84-7 |
详细
|
| Tigulixostat |
化合物 TIGULIXOSTAT |
1287766-55-5 |
详细
|
| SR18662 |
(E)-3-(3,4-dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide |
2505001-62-5 |
详细
|
| CL-349010 |
CL-349010 |
868269-33-4 |
详细
|
| GNE-9815 |
化合物GNE-9815 |
2729996-45-4 |
详细
|
| Ninerafaxstat 3HCl |
化合物NINERAFAXSTAT TRIHYDROCHLORIDE |
2311824-72-1 |
详细
|
| STF-62247 |
N-(3-甲基苯基)-4-(4-吡啶)-2-噻唑胺 |
315702-99-9 |
详细
|
| FIPI |
FIPI |
939055-18-2 |
详细
|
| Mibampator(LY451395) |
MIBAMPATOR |
375345-95-2 |
详细
|
| WS6 |
WS6 |
1421227-53-3 |
详细
|
| BCI-121 |
BCI-121 |
432529-82-3 |
详细
|
| V-9302 |
V-9302 |
1855871-76-9 |
详细
|
| TBK1/IKKε-IN-5 |
Benzonitrile, 5-[4-[[4-[4-(3-oxetanyl)-1-piperazinyl]phenyl]amino]-1,3,5-triazin-2-yl]-2-[(tetrahydro-2H-pyran-4-yl)oxy]- |
1893397-65-3 |
详细
|
| Mebeverine Acid |
美贝维林 盐酸盐 |
475203-77-1 |
详细
|
| 4-[(2-(2-Aminoethoxy)ethyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl |
泊马度胺 4'-PEG1-胺 |
2154342-56-8 |
详细
|
| FABPs ligand 6 |
化合物 FABPS LIGAND 6 |
|
详细
|
| 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]isothiazole |
|
|
详细
|
| A-443654 |
(ALPHAS)-ALPHA-[[[5-(3-甲基-1H-吲唑-5-基)-3-吡啶基]氧基]甲基]-(S)-1H-吲哚-3-乙胺 |
552325-16-3 |
详细
|
| IWP-L6 |
IWP-L6 |
1427782-89-5 |
详细
|
| UNC0379 |
UNC0379 |
1620401-82-2 |
详细
|
| SR10067 |
[3-[[4-(1,1-Dimethylethoxy)phenoxy]methyl]-3,4-dihydro-2(1H)-isoquinolinyl]-1-naphthalenylmethanone |
1380548-02-6 |
详细
|
| LMI070 |
化合物LMI 070 |
1562338-42-4 |
详细
|
| CXCR7 antagonist-1 |
|
1613021-99-0 |
详细
|